RAYMOND JAMES TRUST N.A. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES TRUST N.A. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2021$194,000
-8.1%
11,525
+0.1%
0.01%
-14.3%
Q1 2021$211,000
-52.3%
11,516
-52.5%
0.01%
-58.8%
Q4 2020$442,000
-0.5%
24,246
-2.5%
0.02%
-10.5%
Q3 2020$444,000
+6.5%
24,863
+6.7%
0.02%
-5.0%
Q2 2020$417,000
+16.2%
23,295
-1.5%
0.02%
-4.8%
Q1 2020$359,000
-10.0%
23,660
+16.8%
0.02%
+10.5%
Q4 2019$399,000
+20.5%
20,252
+5.2%
0.02%
+11.8%
Q3 2019$331,000
+31.9%
19,246
+36.1%
0.02%
+21.4%
Q2 2019$251,000
+13.1%
14,140
+29.4%
0.01%
+7.7%
Q1 2019$222,00010,9270.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders